273 related articles for article (PubMed ID: 23094053)
1. Association between proton magnetic resonance spectroscopy measurements and CAG repeat number in patients with spinocerebellar ataxias 2, 3, or 6.
Wang PS; Chen HC; Wu HM; Lirng JF; Wu YT; Soong BW
PLoS One; 2012; 7(10):e47479. PubMed ID: 23094053
[TBL] [Abstract][Full Text] [Related]
2. Differences between spinocerebellar ataxias and multiple system atrophy-cerebellar type on proton magnetic resonance spectroscopy.
Lirng JF; Wang PS; Chen HC; Soong BW; Guo WY; Wu HM; Chang CY
PLoS One; 2012; 7(10):e47925. PubMed ID: 23118909
[TBL] [Abstract][Full Text] [Related]
3. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds.
Tang B; Liu C; Shen L; Dai H; Pan Q; Jing L; Ouyang S; Xia J
Arch Neurol; 2000 Apr; 57(4):540-4. PubMed ID: 10768629
[TBL] [Abstract][Full Text] [Related]
4. CAG repeat length does not associate with the rate of cerebellar degeneration in spinocerebellar ataxia type 3.
Huang SR; Wu YT; Jao CW; Soong BW; Lirng JF; Wu HM; Wang PS
Neuroimage Clin; 2017; 13():97-105. PubMed ID: 27942452
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance spectroscopy of the cerebellum in patients with spinocerebellar ataxia type 3/Machado-Joseph disease.
Lei L; Liao Y; Liao W; Zhou J; Yuan Y; Wang J; Jiang H; Shen L; Tang B
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 36(6):511-9. PubMed ID: 21743142
[TBL] [Abstract][Full Text] [Related]
6. Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study.
Jacobi H; du Montcel ST; Romanzetti S; Harmuth F; Mariotti C; Nanetti L; Rakowicz M; Makowicz G; Durr A; Monin ML; Filla A; Roca A; Schöls L; Hengel H; Infante J; Kang JS; Timmann D; Casali C; Masciullo M; Baliko L; Melegh B; Nachbauer W; Bürk-Gergs K; Schulz JB; Riess O; Reetz K; Klockgether T
Lancet Neurol; 2020 Sep; 19(9):738-747. PubMed ID: 32822634
[TBL] [Abstract][Full Text] [Related]
7. Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A quantitative volumetric, diffusion and proton spectroscopy MR study.
Guerrini L; Lolli F; Ginestroni A; Belli G; Della Nave R; Tessa C; Foresti S; Cosottini M; Piacentini S; Salvi F; Plasmati R; De Grandis D; Siciliano G; Filla A; Mascalchi M
Brain; 2004 Aug; 127(Pt 8):1785-95. PubMed ID: 15240431
[TBL] [Abstract][Full Text] [Related]
8. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.
Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Kang JS; Pandolfo M; Schulz JB; Molho S; Diallo A; Klockgether T
Lancet Neurol; 2015 Nov; 14(11):1101-8. PubMed ID: 26377379
[TBL] [Abstract][Full Text] [Related]
9. Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms.
Schmitz-Hübsch T; Coudert M; Bauer P; Giunti P; Globas C; Baliko L; Filla A; Mariotti C; Rakowicz M; Charles P; Ribai P; Szymanski S; Infante J; van de Warrenburg BP; Dürr A; Timmann D; Boesch S; Fancellu R; Rola R; Depondt C; Schöls L; Zdienicka E; Kang JS; Döhlinger S; Kremer B; Stephenson DA; Melegh B; Pandolfo M; di Donato S; du Montcel ST; Klockgether T
Neurology; 2008 Sep; 71(13):982-9. PubMed ID: 18685131
[TBL] [Abstract][Full Text] [Related]
10. Spinocerebellar ataxias types 1, 2 and 3: age adjusted clinical severity of disease at presentation correlates with size of CAG repeat lengths.
Netravathi M; Pal PK; Purushottam M; Thennarasu K; Mukherjee M; Jain S
J Neurol Sci; 2009 Feb; 277(1-2):83-6. PubMed ID: 19049837
[TBL] [Abstract][Full Text] [Related]
11. The merit of proton magnetic resonance spectroscopy in the longitudinal assessment of spinocerebellar ataxias and multiple system atrophy-cerebellar type.
Chen HC; Lirng JF; Soong BW; Guo WY; Wu HM; Chen CC; Chang CY
Cerebellum Ataxias; 2014; 1():17. PubMed ID: 26331041
[TBL] [Abstract][Full Text] [Related]
12. Survival in patients with spinocerebellar ataxia types 1, 2, 3, and 6 (EUROSCA): a longitudinal cohort study.
Diallo A; Jacobi H; Cook A; Labrum R; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sobanska A; Sulek A; Schmitz-Hübsch T; Schöls L; Hengel H; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Boesch S; Pandolfo M; Schulz JB; Bauer P; Giunti P; Kang JS; Klockgether T; Tezenas du Montcel S
Lancet Neurol; 2018 Apr; 17(4):327-334. PubMed ID: 29553382
[TBL] [Abstract][Full Text] [Related]
13. Comparable progression of spinocerebellar ataxias between Caucasians and Chinese.
Lin YC; Lee YC; Hsu TY; Liao YC; Soong BW
Parkinsonism Relat Disord; 2019 May; 62():156-162. PubMed ID: 30591349
[TBL] [Abstract][Full Text] [Related]
14. Neurochemical abnormalities in premanifest and early spinocerebellar ataxias.
Joers JM; Deelchand DK; Lyu T; Emir UE; Hutter D; Gomez CM; Bushara KO; Eberly LE; Öz G
Ann Neurol; 2018 Apr; 83(4):816-829. PubMed ID: 29575033
[TBL] [Abstract][Full Text] [Related]
15. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.
Jacobi H; Reetz K; du Montcel ST; Bauer P; Mariotti C; Nanetti L; Rakowicz M; Sulek A; Durr A; Charles P; Filla A; Antenora A; Schöls L; Schicks J; Infante J; Kang JS; Timmann D; Di Fabio R; Masciullo M; Baliko L; Melegh B; Boesch S; Bürk K; Peltz A; Schulz JB; Dufaure-Garé I; Klockgether T
Lancet Neurol; 2013 Jul; 12(7):650-8. PubMed ID: 23707147
[TBL] [Abstract][Full Text] [Related]
16. Frequency analysis and clinical characterization of spinocerebellar ataxia types 1, 2, 3, 6, and 7 in Korean patients.
Lee WY; Jin DK; Oh MR; Lee JE; Song SM; Lee EA; Kim GM; Chung JS; Lee KH
Arch Neurol; 2003 Jun; 60(6):858-63. PubMed ID: 12810491
[TBL] [Abstract][Full Text] [Related]
17. Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6.
Schulz JB; Borkert J; Wolf S; Schmitz-Hübsch T; Rakowicz M; Mariotti C; Schöls L; Timmann D; van de Warrenburg B; Dürr A; Pandolfo M; Kang JS; Mandly AG; Nägele T; Grisoli M; Boguslawska R; Bauer P; Klockgether T; Hauser TK
Neuroimage; 2010 Jan; 49(1):158-68. PubMed ID: 19631275
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of SCA2 from MSA-C using proton magnetic resonance spectroscopic imaging.
Boesch SM; Wolf C; Seppi K; Felber S; Wenning GK; Schocke M
J Magn Reson Imaging; 2007 Mar; 25(3):564-9. PubMed ID: 17326083
[TBL] [Abstract][Full Text] [Related]
19. Neurochemical profiles in hereditary ataxias: A meta-analysis of Magnetic Resonance Spectroscopy studies.
Krahe J; Binkofski F; Schulz JB; Reetz K; Romanzetti S
Neurosci Biobehav Rev; 2020 Jan; 108():854-865. PubMed ID: 31838195
[TBL] [Abstract][Full Text] [Related]
20. Spinocerebellar ataxias in the Netherlands: prevalence and age at onset variance analysis.
van de Warrenburg BP; Sinke RJ; Verschuuren-Bemelmans CC; Scheffer H; Brunt ER; Ippel PF; Maat-Kievit JA; Dooijes D; Notermans NC; Lindhout D; Knoers NV; Kremer HP
Neurology; 2002 Mar; 58(5):702-8. PubMed ID: 11889231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
